Caribou Biosciences (CRBU) EPS (Basic) (2020 - 2026)
Caribou Biosciences (CRBU) reported EPS (Basic) of -$0.26 for Q1 2026, up 39.53% year-over-year from -$0.19 in Q1 2025, and up 7.14% quarter-over-quarter from -$0.28 in Q4 2025.
Caribou Biosciences (CRBU) EPS (Basic) (2020 - 2026) Analysis & Trends
Caribou Biosciences (CRBU) has 7 years of EPS (Basic) data on file, last reported at -$0.26 in Q1 2026.
- EPS (Basic) for Q1 2026 came in at -$0.26, up 39.53% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.42 (up 12.35% YoY), and the FY2025 annual result was -$1.59, up 3.64% from the prior year.
- EPS (Basic) advanced to -$0.26 in Q1 2026 per CRBU's latest filing, from -$0.28 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.12 in Q3 2023 and troughed at -$0.58 in Q2 2025.
- A 5-year average of -$0.39 and a median of -$0.42 in 2024 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2024: EPS (Basic) soared 76.98% in 2022, then tumbled 216.67% in 2024.
- A 5-year view of EPS (Basic) shows it stood at -$0.45 in 2022, then increased by 11.11% to -$0.4 in 2023, then advanced by 2.5% to -$0.39 in 2024, then increased by 28.21% to -$0.28 in 2025, then grew by 7.14% to -$0.26 in 2026.
- Business Quant data shows CRBU's EPS (Basic) at -$0.26 in Q1 2026, -$0.28 in Q4 2025, and -$0.3 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Caribou Biosciences | 156.73 Mn | 39.11 Mn | - | -0.26 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.26 |
| Dec 31, 2025 | -0.28 |
| Sep 30, 2025 | -0.30 |
| Jun 30, 2025 | -0.58 |
| Mar 31, 2025 | -0.43 |
| Dec 31, 2024 | -0.39 |
| Sep 30, 2024 | -0.38 |
| Jun 30, 2024 | -0.42 |
| Mar 31, 2024 | -0.46 |
| Dec 31, 2023 | -0.40 |
| Sep 30, 2023 | -0.12 |
| Jun 30, 2023 | -0.48 |
| Mar 31, 2023 | -0.46 |
| Dec 31, 2022 | -0.45 |
| Sep 30, 2022 | -0.44 |
| Jun 30, 2022 | -0.44 |
| Mar 31, 2022 | -0.32 |
| Dec 31, 2021 | -0.31 |
| Sep 30, 2021 | -0.46 |
| Jun 30, 2021 | -1.39 |